Corbus Pharmaceuticals Holdings (CRBP) Shares Outstanding (2013 - 2025)

Corbus Pharmaceuticals Holdings' Shares Outstanding (Entity) history runs 13 years deep, the most recent figure standing at $17.6 million for Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 44.6% year-over-year to $17.6 million in Q4 2025; TTM through Dec 2025 was $17.6 million, a 44.6% increase from a year earlier, with the FY2025 full-year figure at $17.6 million, up 44.6% from the prior year.
• Shares Outstanding (Entity) climbed to $17.6 million in Q4 2025 per CRBP's latest filing, from $12.5 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $17.6 million in Q4 2025 and bottomed at $4.2 million in Q1 2021.
• The 5-year median for Shares Outstanding (Entity) is $4.4 million (2023), against an average of $7.5 million.
• Across the five-year window, Shares Outstanding (Entity) slipped 0.06% in 2022 and jumped 175.32% in 2024, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $4.2 million in 2021, then retreated by 0.06% to $4.2 million in 2022, then increased by 6.05% to $4.4 million in 2023, then surged by 175.32% to $12.2 million in 2024, then jumped by 44.6% to $17.6 million in 2025.
• Per Business Quant, the three latest CRBP Shares Outstanding (Entity) figures stand at $17.6 million (Q4 2025), $12.5 million (Q3 2025), and $12.3 million (Q2 2025).